Plain-English translation of NCT03900221 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term registry study that follows pregnant women diagnosed with multiple sclerosis (or related neurological conditions) and their children from pregnancy through age 6. Researchers want to understand how pregnancy affects MS, how MS medications taken before or during pregnancy affect both mother and baby, and answer other important questions about pain management and breastfeeding.
Doctors and patients don't have enough clear information about the risks and benefits of MS medications during pregnancy and after delivery. This study will help fill that gap by carefully tracking real pregnancies and outcomes over time.
You likely qualify if…
You likely don't qualify if…
You would be followed by your neurologist throughout your pregnancy and for one year after delivery, with your child followed until age 6. The study involves sharing your medical information, pregnancy details, and your child's health records with the French MS registry. Visits would happen as part of your regular care with your neurologist—this is not a treatment study, but rather careful monitoring and data collection to help future patients.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
France